BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11527885)

  • 1. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia.
    Bath LE; Anderson RA; Critchley HO; Kelnar CJ; Wallace WH
    Hum Reprod; 2001 Sep; 16(9):1838-44. PubMed ID: 11527885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of reproductive hormonal dynamics in the perimenopause.
    Santoro N; Brown JR; Adel T; Skurnick JH
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-ovarian function in menstruating women with Turner syndrome (45,X).
    Page LA; Beauregard LJ; Bode HH; Beitins IZ
    Pediatr Res; 1990 Nov; 28(5):514-7. PubMed ID: 2255575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.
    De Souza MJ; Miller BE; Loucks AB; Luciano AA; Pescatello LS; Campbell CG; Lasley BL
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4220-32. PubMed ID: 9851755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    Dahl KD; Czekala NM; Lim P; Hsueh AJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone.
    Beitins IZ; McArthur JW; Turnbull BA; Skrinar GS; Bullen BA
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1350-8. PubMed ID: 1902847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of subchronic infusion of dehydroepiandrosterone sulfate on serum gonadotropin levels and ovarian function in the cynomolgus monkey.
    Kowalski W; Chatterton RT
    Fertil Steril; 1992 Apr; 57(4):912-20. PubMed ID: 1532562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiatergic influence on gonadotropin-releasing hormone and luteinizing hormone release during the macaque menstrual cycle.
    Pau KY; Berria M; Hess DL; Spies HG
    Biol Reprod; 1996 Aug; 55(2):478-84. PubMed ID: 8828858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary hormone analysis as a diagnostic tool to evaluate the ovarian function of female gorillas (Gorilla gorilla).
    Czekala NM; Roser JF; Mortensen RB; Reichard T; Lasley BL
    J Reprod Fertil; 1988 Jan; 82(1):255-61. PubMed ID: 3339583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
    Matthews KA; Santoro N; Lasley B; Chang Y; Crawford S; Pasternak RC; Sutton-Tyrrell K; Sowers M
    J Clin Endocrinol Metab; 2006 May; 91(5):1789-95. PubMed ID: 16492698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.